Nano-X Imaging (NNOX) Cash from Investing Activities (2021 - 2026)
Nano-X Imaging's (NNOX) quarterly Cash from Investing Activities came in at $8.7 million in Q1 2026, down 22.94% YoY from $11.3 million in Q1 2025, and up 887.13% on a QoQ basis from -$1.1 million in Q4 2025.
Nano-X Imaging (NNOX) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has 6 years of Cash from Investing Activities data on file, last reported at $8.7 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 22.94% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.8 million (up 498.63% YoY) and the FY2025 annual result came in at $29.4 million, up 246.49% from the prior year.
- Cash from Investing Activities grew to $8.7 million in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $18.9 million in Q2 2025 to a low of -$26.2 million in Q4 2024.
- A 5-year average of $4.0 million and a median of $5.7 million in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 958.57% — and 2024, when it plunged 1254.0%.
- Tracing NNOX's Cash from Investing Activities over 5 years: stood at $12.8 million in 2022, then sank by 82.19% to $2.3 million in 2023, then slumped by 1254.0% to -$26.2 million in 2024, then soared by 95.8% to -$1.1 million in 2025, then jumped by 887.13% to $8.7 million in 2026.
- The last three Cash from Investing Activities figures came in at $8.7 million (Q1 2026), -$1.1 million (Q4 2025), and $260000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Nano-X Imaging | 62,831.15 | -44.16 Mn | -2.59 Mn | 8.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 18.95 Mn |
| Jun 30, 2025 | 18.95 Mn |
| Mar 31, 2025 | 11.27 Mn |
| Mar 31, 2025 | 11.27 Mn |
| Dec 31, 2024 | -26.24 Mn |
| Dec 31, 2024 | -26.24 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Dec 31, 2023 | 2.27 Mn |